Evidence map›Paper›PMID 37834338›Full record

ArticleInternational journal of molecular sciences2023

Factors Influencing Marker Expressions of Cultured Human Cord Blood-Derived Mast Cells.

Shahrzad Alimohammadi, Kana Masuda-Kuroki, Attila Gábor Szöllősi, Anna Di Nardo

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Mast Cells in Human Health and Diseases 2.0.International journal of molecular sciences · 2024
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Shahrzad AlimohammadiDepartment of Dermatology, School of Medicine, University of California San Diego, La Jolla, CA 92037, USA.ORCID 0000-0002-4867-9337
Kana Masuda-KurokiDepartment of Dermatology, School of Medicine, University of California San Diego, La Jolla, CA 92037, USA.ORCID 0000-0003-0425-6858
Attila Gábor SzöllősiDoctoral School of Molecular Medicine, University of Debrecen, 4032 Debrecen, Hungary.ORCID 0000-0001-6046-8236
Anna Di NardoDepartment of Dermatology, School of Medicine, University of California San Diego, La Jolla, CA 92037, USA.ORCID 0000-0002-5575-9968
University of California San Diego · USUniversity of Debrecen · HU

Funding

Mast cells in skin innate immune defenseR01AI093957 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DI NARDO, ANNA · 2011 to 2023
$4.6M
NIAID NIH HHS R01 AI093957
6 · The paper itself

Abstract

Mast cells (MCs) are tissue-resident immune cells of a hematopoietic origin that play vital roles in innate and adaptive immunity. Human MCs can be isolated and differentiated from various tissue sources, including cord blood, when supplemented with cytokines such as stem cell factor, interleukin 3, and interleukin 6. Our current research study has shown significant differences in the marker expressions of human cord blood-derived mast cells (hCBMCs) based on donor dependency and the type of medium used for culturing and differentiation. These findings are particularly relevant given the challenges of obtaining specialty media influencing MC phenotypic marker expressions. We found that hCBMCs cultured in StemSpanTM-XF medium had a moderate expression of mast/stem cell growth factor receptor Kit (c-KIT) (mRNA and protein), low expressions of FcεRI (mRNA) and TLR2 (mRNA and protein) but had high levels of MRGPRX2 (mRNA and protein) expressions. In contrast, hCBMCs cultured in Stem Line II medium expressed FcεRI and TLR2 (mRNA and protein) with higher c-KIT but had lower MRGPRX2 expressions compared to the hCBMCs cultured in the StemSpanTM-XF medium. These results suggest that it is crucial to consider both donor dependency and the medium when investigating MC functions and that further research is needed to fully understand the impact of these factors on the hCBMC marker expressions.

Indexed as

Fetal BloodMast CellsCell DifferentiationCells, CulturedHumansNerve Tissue ProteinsReceptors, G-Protein-CoupledReceptors, NeuropeptideRNA, MessengerToll-Like Receptor 2MRGPRX2 protein, humanNerve Tissue ProteinsReceptors, G-Protein-CoupledReceptors, NeuropeptideRNA, MessengerToll-Like Receptor 2CD34+ cord blood-derived mast cellschymasec-KITFcεRIhuman stem cellsimmune responseMRGPRX2TLR2tryptase

Identifiers

PMID37834338
PMCPMC10573221
OpenAlexW4387342076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.